首页> 外文期刊>Methods: A Companion to Methods in Enzymology >Animal models to test respiratory allergy of low molecular weight chemicals: a guidance.
【24h】

Animal models to test respiratory allergy of low molecular weight chemicals: a guidance.

机译:测试低分子量化学品呼吸道过敏的动物模型:指导。

获取原文
获取原文并翻译 | 示例
           

摘要

At present, there are no widely applied or fully validated test methods to identify respiratory LMW allergens, i.e. compounds that are considered capable of inducing allergic asthma. Most tests have been investigated using strong respiratory allergens. Moreover, they are meant to detect the potential of a chemical to induce respiratory sensitisation at relatively high doses. Consequently, the sensitivity of the tests is not well-known, and they do not provide information on low doses such as generally found in occupational situations, and on threshold levels to be used in risk assessment. In addition, the various test methods use different application routes, i.e. intradermal, topical or inhalation exposure, and different parameters. Therefore standardised and validated dose-response test methods are urgently required in order to be able to identify respiratory allergens and to recommend safe exposure levels for consumers and workers. In the present paper, methods or testing strategies are described todetect respiratory sensitisation and/or allergy. Overall, assays that utilize only an induction phase may serve as indicators of respiratory sensitisation potential whereas assays that use both an induction and an elicitation or challenge phase may provide information on potency and presence of thresholds. The dermal route as sensitisation route has the advantage of the respiratory tract not being exposed to the allergen prior to challenge which facilitates the distinction between irritant and allergic effects.
机译:目前,尚没有广泛应用或经过充分验证的测试方法来鉴定呼吸道LMW过敏原,即被认为能够诱导过敏性哮喘的化合物。大多数测试已使用强烈的呼吸道过敏原进行了调查。而且,它们旨在检测化学药品在较高剂量下诱发呼吸道致敏作用的潜力。因此,测试的敏感性尚不为人所知,并且它们没有提供有关低剂量(例如通常在职业情况下发现)以及用于风险评估的阈值水平的信息。另外,各种测试方法使用不同的施用途径,即皮内,局部或吸入暴露以及不同的参数。因此,迫切需要标准化和经过验证的剂量反应测试方法,以便能够识别呼吸道过敏原并为消费者和工人推荐安全的暴露水平。在本文中,描述了检测呼吸道过敏和/或过敏的方法或测试策略。总体而言,仅利用诱导期的测定可作为呼吸致敏潜力的指标,而同时使用诱导期和诱导或激发期的测定可提供有关效价和阈值存在的信息。皮肤途径作为致敏途径的优点是在攻击之前呼吸道不暴露于过敏原,这有助于区分刺激性和过敏性作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号